OSMR

OSMR

OSMR Overview

Molecule Name
Oncostatin-M-specific receptor subunit beta
Synonyms
Oncostatin-M-specific receptor subunit beta,Interleukin-31 receptor subunit beta,IL-31 receptor subunit beta,IL-31R subunit beta,IL-31R-beta,IL-31RB,OSMR,OSMRB
Drug Development Progress
Drugs in Clinical Trials1
Approved Drugs0
Highest Development StagePhase 2 Clinical
Target Synonym
IL-31R-beta,IL-31RB,Interleukin-31 receptor subunit beta,IL-31 receptor subunit beta,IL-31R subunit beta
Background
Oncostatin-M-specific receptor subunit beta (OSMRβ), also known as Interleukin-31 receptor subunit beta (IL-31RB), is the beta subunit of the type II OSM receptor, which is a heterodimer of gp130 and OSMRβ. OSMRβ associates with the low-affinity OSM·gp130 complex to form a high-affinity heterodimeric receptor that is capable of transducing OSM-specific signaling events.

OSMR Product List

Species
  • Human(3)
  • Canine(1)
  • Cynomolgus(1)
  • Rabbit(1)
  • Rat(1)
Tag
  • His Tag(5)
  • Fc Tag(1)
  • His Tag & Avi Tag(1)
Host
  • HEK293(7)
Conjugate
  • Unconjugated(6)
  • Biotin-labeled(1)
Grade
  • RUO(7)
Low Endotoxin
  • Yes(3)
  • No(4)
MoleculeCat. No.Product NameSpeciesHostStructurePurityActivitySize&PriceAdd to Cart
OSMR
Cynomolgus OSMR beta Protein, His Tag, low endotoxin (MALS verified)
Cynomolgus
HEK293
MALSSDS-PAGE

$395.00

100ug
OSMR
Canis lupus OSMR beta Protein, His Tag (MALS verified)
Canine
HEK293
MALSSDS-PAGE

$410.00

100ug
OSMR
Human OSMR beta Protein, Fc Tag, low endotoxin (MALS verified)
Human
HEK293
MALSSDS-PAGE
ELISA

$395.00

100ug
OSMR
Human OSMR beta Protein, His Tag, low endotoxin (MALS verified)
Human
HEK293
MALSSDS-PAGE

$430.00

100ug
OSMR
Avitag
OSR-H82E3
Biotinylated Human OSMR beta Protein, His,Avitag™ (MALS verified)
Human
HEK293
MALSSDS-PAGE
ELISA

$360.00

25ug
OSMR
Rabbit OSMR beta Protein, His Tag (MALS verified)
Rabbit
HEK293
MALSSDS-PAGE

$395.00

100ug
OSMR
Rat OSMR beta Protein, His Tag (MALS verified)
Rat
HEK293
MALSSDS-PAGE

$395.00

100ug
You Have Viewed 1-7 Of 7 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

Asset Licensing Opportunity
Resources

Clinical Drug Information

English NameResearch CodeHighest Development StageCompanyIndicationClinical Trial
VixarelimabKPL-716; BIIB-069; RG-6536; RO-7622888Phase 2 ClinicalBiogen Inc
Chronic Urticaria; Colitis, Ulcerative; Lichen Planus; Neurodermatitis; Plaque psoriasis; Prurigo Nodularis; Pruritus
Details
Customer Reviews